Hutch News

Hutch News

Stories tagged 'Cancers'

His immune system eradicated his melanoma. Could other patients’ bodies be taught to do the same thing?

How one man’s T cells are guiding the development of next-gen immunotherapies

June 19, 2018 | by Susan Keown / Fred Hutch News Service

Chris Pope's immune system eradicated his stage 4 melanoma on an immunotherapy clinical trial. Is it possible to genetically reprogram other patients' to do the same thing?

View story >


How one protein helps cancer both spread and grow

Hutch scientists discover single molecule’s ‘intricate regulation’ of two key aspects of metastasis

June 18, 2018 | By Sabrina Richards / Fred Hutch News Service

Hutch researchers discover how one protein controls both cell spread and growth during metastasis.

View story >


ASCO endorses integrative oncology guidelines for breast cancer patients

Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment

June 11, 2018 | By Diane Mapes / Fred Hutch News Service

Breast cancer patients looking to relieve the side effects of conventional treatment may be happy to learn that the world's leading professional organization of cancer doctors, ASCO, has just endorsed a handful of integrative therapies as evidenced-based ways to manage treatment-related fatigue, pain, nausea, anxiety and more.

View story >


At half the cost, Canadian colorectal cancer survival similar to U.S.

Cross-border collaboration compared findings in British Columbia and Washington state

June 1, 2018 | By Sabin Russell / Fred Hutch News Service

In a rare comparison of cancer care in neighboring regions of the U.S. and Canada, a new study found Americans were paying twice as much for similar colorectal cancer treatments, with no advantage in survival rates.

View story >


3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


Biologics and biosimilars step onto the cancer therapy stage

Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?

May 31, 2018 | By Diane Mapes / Fred Hutch News Service

Costly biologics and their "generic-ish" counterparts, biosimilars, are about to step into the pharmaceutical spotlight in a big way. We sat down with Fred Hutch's Dr. Gary Lyman, an oncologist and national thought leader on health economics, to learn more about burgeoning biopharmaceuticals.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.